1329P - Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy
| Autor: | Hernando Cubero, J., Grande, E., Jimenez Fonseca, P., Villabona, C., Trigo Perez, J.M., Martinez Trufero, J., Pajares Bernad, I., Lopez, C., Alonso, T., Biarnes, J., RamónY Cajal, T., Duran, M., Grau, J.J., Arevalo Lobera, S., Mesia Nin, R., Llanos, M., Dalmau Portulas, E., Alvarez, C., Zafon, C., Capdevila, J. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|